← 產業報告目錄

Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2026-01-22頁數 715報告編號 BT2697

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The next-generation sequencing market is expected to reach USD 29.53 billion in 2030, up from USD 14.94 billion in 2025, at a CAGR of 14.6% during the forecast period. The growing application of NGS in oncology, infectious diseases, reproductive health, metagenomics, and personalized medicine is the primary driver of market expansion. Meanwhile, advanced bioinformatics tools for data analysis and interpretation are facilitating the use of NGS, thereby helping a wider user base adopt the technique. “Consumables accounted for the largest share of the product segment in the NGS market in 2024.” The NGS products market is segmented into consumables, platforms, and bioinformatics tools. In 2024, consumables held the largest share. This segment includes reagents, library preparation kits, sequencing flow cells, and sample preparation kits, which are used in high volumes across many applications. Demand remains robust because consumables are purchased repeatedly, unlike instruments, which are generally one-time investments. The growing use of targeted sequencing and custom panels is also driving demand for specialized, application-specific consumables. Furthermore, an expanding user base and ongoing improvements in sequencing chemistries are drawing more customers toward consumables to simplify their workflows and improve data quality.   “The academic & research institutes segment accounted for the largest share by services end-user segment in the next-generation sequencing market in 2024.” The next-generation sequencing services market is segmented by end user into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & clinical laboratories, and other users. In 2024, academic and research institutes held the largest share. This leadership is supported by strong government and private funding for research programs, enabling higher spending on NGS-related needs, including instruments and consumables. Pharmaceutical and biotechnology companies represented the second-largest end-user segment in the market. “The Asia Pacific region will grow at the highest CAGR from 2025 to 2030.” The Asia Pacific region is estimated to be the fastest-growing segment of the market, owing to large-scale population genomics projects and rising demand for precision medicines. Additionally, the rising prevalence of rare and genetic diseases is attributed to the aging populations in countries such as Japan and China. These factors are supporting the adoption of sequencing technologies in healthcare management and treatment, driving market growth. The primary interviews conducted for this report can be categorized as follows: • By Respondent: Supply Side- 70% and Demand Side 30% • By Designation: Managers - 45% CXOs and Director-level - 30%, and Executives - 25%, • By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5%, and Middle East -5%. List of Companies Profiled in the Report: • Illumina, Inc. (US) • Thermo Fisher Scientific Inc. (US) • F. Hoffmann-La Roche Ltd. (Switzerland) • Danaher Corporation (US) • QIAGEN (Netherlands) • Agilent Technologies, Inc. (US) • Revvity (US) • Eurofins Scientific (Luxembourg) • PacBio (US) • Oxford Nanopore Technologies plc. (UK) • Takara Bio Inc. (Japan) • BGI Group (China) • Merck KGaA (Germany) • BD (US) • 10X Genomics (US) • New England Biolabs (US) • Promega Corporation (US) • Novogene Co., Ltd. (China) • LGC Limited (UK) • WuXi Biologics (China) • MGI Tech Co. Ltd. (China) • Tecan Trading AG (Switzerland) • Twist Biosciences (US) • Azenta US, Inc. (US) • GenScript (US) • SD Biosensor, Inc. (South Korea) • Fulgent Genetics (US) • Hamilton Company (US) • Zymo Research Corporation (US) • NeoGenomics Laboratories (US) • Psomagen (US) Research Coverage: The scope of the report covers detailed information on the major factors, such as drivers, challenges, opportunities, and restraints, that influence the growth of the NGS market. A detailed analysis of key industry players has been conducted to provide insights into their business overview, product and service portfolio, key strategies such as product and service launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the NGS market. Competitive analysis of top players and upcoming startups in the NGS market ecosystem is also covered in this report. Key Benefits of Buying the Report: The report will help market leaders and new entrants by providing the closest approximations of revenue for the overall NGS market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain insights to better position their business and develop suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide information on the key market drivers, restraints, opportunities, and challenges. The report provides insights into the following points: Analysis of key drivers (advancements in sequencing platforms, rising clinical applications of sequencing, growing demand for precision medicine, declining sequencing costs), restraints (complex data analysis, high initial capital investment), opportunities (integration of AI and ML, adoption of long-read sequencing technologies, emphasis on multiomics integration), and challenges (standardization issues) influencing the growth of the market. • Product Development/Innovation: Detailed insights on newly launched products/services of the next-generation sequencing market • Market Development: Comprehensive information about lucrative markets - the report analyzes the market across varied regions • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the next-generation sequencing market • Competitive Assessment: Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), QIAGEN (Netherlands), Agilent Technologies, Inc. (US), Revvity (US), Eurofins Scientific (Luxembourg), PacBio (US), Oxford Nanopore Technologies plc. (UK), Takara Bio Inc. (Japan), BGI Group (China), Merck KGaA (Germany), BD (US), 10X Genomics (US), New England Biolabs (US), Promega Corporation (US), Novogene Co., Ltd. (China), LGC Limited (UK), WuXi Biologics (China), MGI Tech Co. Ltd. (China), Tecan Trading AG (Switzerland), Twist Biosciences (US), Azenta US, Inc. (US), GenScript (US), SD Biosensor, Inc. (South Korea), Fulgent Genetics (US), Hamilton Company (US), Zymo Research Corporation (US), NeoGenomics Laboratories (US), and Psomagen (US)
目錄 Table of Contents
1 INTRODUCTION 58 1.1 STUDY OBJECTIVES 58 1.2 MARKET DEFINITION 58 1.3 STUDY SCOPE 59 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 59 1.3.2 INCLUSIONS & EXCLUSIONS 60 1.4 YEARS CONSIDERED 61 1.5 CURRENCY CONSIDERED 61 1.6 STAKEHOLDERS 62 1.7 SUMMARY OF CHANGES 62 2 EXECUTIVE SUMMARY 63 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 63 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 64 2.3 DISRUPTIVE TRENDS IN NEXT-GENERATION SEQUENCING MARKET 65 2.4 HIGH-GROWTH SEGMENTS 66 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 67 3 PREMIUM INSIGHTS 68 3.1 NEXT-GENERATION SEQUENCING MARKET OVERVIEW 68 3.2 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY OFFERING AND COUNTRY 69 3.3 NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY 70 3.4 NEXT-GENERATION SEQUENCING MARKET, BY OFFERING, 2026 VS. 2031 (%) 70 4 MARKET OVERVIEW 71 4.1 INTRODUCTION 71 4.2 MARKET DYNAMICS 71 4.2.1 DRIVERS 72 4.2.1.1 Advancements in sequencing platforms 72 4.2.1.2 Rising clinical applications of sequencing 73 4.2.1.3 Growing demand for precision medicine 73 4.2.1.4 Declining costs of sequencing 73 4.2.2 RESTRAINTS 74 4.2.2.1 Data analysis complexity 74 4.2.2.2 High capital investments and expenses 74 4.2.3 OPPORTUNITIES 74 4.2.3.1 Integration of AI and ML 74 4.2.3.2 Adoption of long-read sequencing technologies 75 4.2.3.3 Emphasis on multiomics integration 75 4.2.4 CHALLENGES 76 4.2.4.1 Standardization issues 76 4.3 UNMET NEEDS AND WHITE SPACES 76 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 76 4.5 STRATEGIC MOVIES BY TIER 1/2/3 PLAYERS 77 5 INDUSTRY TRENDS 78 5.1 PORTER’S FIVE FORCES ANALYSIS 78 5.1.1 INTENSITY OF COMPETITIVE RIVALRY 79 5.1.2 BARGAINING POWER OF SUPPLIERS 79 5.1.3 BARGAINING POWER OF BUYERS 80 5.1.4 THREAT FROM SUBSTITUTES 80 5.1.5 THREAT FROM NEW ENTRANTS 80 5.2 MACROECONOMIC OUTLOOK 80 5.2.1 INTRODUCTION 80 5.2.2 GDP TRENDS AND FORECAST 81 5.2.3 R&D TRENDS IN GLOBAL HEALTHCARE INDUSTRY 81 5.2.4 R&D TRENDS IN GLOBAL BIOTECH INDUSTRY 82 5.3 VALUE CHAIN ANALYSIS 82 5.4 ECOSYSTEM ANALYSIS 83 5.4.1 ROLE OF PLAYERS IN ECOSYSTEM 85 5.5 PRICING ANALYSIS 86 5.5.1 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER 86 5.5.1.1 Average selling price trend of platforms, by key player 86 5.5.1.2 Average selling price trend of consumables, by key player 87 5.5.2 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER 88 5.5.3 AVERAGE SELLING PRICE TREND, BY REGION 89 5.6 TRADE ANALYSIS 90 5.6.1 IMPORT SCENARIO (HS CODE 382200) 91 5.6.2 EXPORT SCENARIO (HS CODE 382200) 93 5.6.3 IMPORT SCENARIO (HS CODE 902700) 95 5.6.4 EXPORT SCENARIO (HS CODE 902700) 97 5.7 KEY CONFERENCES & EVENTS, 2026–2027 99 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 100 5.9 INVESTMENT & FUNDING SCENARIO 100 5.10 CASE STUDY ANALYSIS 101 5.10.1 COMPREHENSIVE GENOMIC PROFILING TEST EXPANDS PRECISION ONCOLOGY APPLICATIONS 101 5.10.2 ULTRA-SENSITIVE NGS PANEL ENABLES MEASURABLE RESIDUAL DISEASE MONITORING 102 5.10.3 NGS-BASED MYELOID FUSION PANEL ENHANCES HEMATOLOGIC MALIGNANCY RESEARCH 102 5.11 IMPACT OF 2025 US TARIFF ON NEXT-GENERATION SEQUENCING MARKET 102 5.11.1 INTRODUCTION 102 5.11.2 KEY TARIFF RATES 103 5.11.3 PRICE IMPACT ANALYSIS 104 5.11.4 IMPACT ON COUNTRY/REGION 104 5.11.4.1 US 104 5.11.4.2 Europe 105 5.11.4.3 Asia Pacific 105 5.11.5 IMPACT ON END-USE INDUSTRIES 105 5.11.5.1 Pharmaceutical & biotechnology companies 106 5.11.5.2 CROs and academic & research institutes 106 5.11.5.3 Hospitals, diagnostic laboratories, and clinics 106 6 CUSTOMER LANDSCAPE & BUYER BEHAVIOUR 107 6.1 DECISION-MAKING PROCESS 107 6.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 107 6.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 107 6.2.2 KEY BUYING CRITERIA FOR NGS PRODUCTS, BY END USER 108 6.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 109 6.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 109 7 SUSTAINABILITY AND REGULATORY LANDSCAPE 111 7.1 REGIONAL REGULATIONS AND COMPLIANCE 111 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111 7.1.2 INDUSTRY STANDARDS 113 7.1.2.1 North America 113 7.1.2.2 Europe 114 7.1.2.3 Asia Pacific 114 7.1.2.4 Rest of the world 115 7.2 SUSTAINABILITY INITIATIVES 115 7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 115 7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 116 8 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 118 8.1 TECHNOLOGY ANALYSIS 118 8.1.1 KEY TECHNOLOGIES 118 8.1.1.1 Sequencing by synthesis 118 8.1.1.2 Ion semiconductor sequencing 118 8.1.1.3 Nanopore sequencing 119 8.1.1.4 Single-molecule real-time sequencing (SMRT) 119 8.1.2 COMPLEMENTARY TECHNOLOGIES 120 8.1.2.1 Automated sample preparation systems 120 8.1.2.2 Bioinformatics and data analysis platforms 120 8.1.2.3 CRISPR-based targeted sequencing 121 8.1.2.4 Multiplex PCR 121 8.1.3 ADJACENT TECHNOLOGIES 121 8.1.3.1 Single-cell sequencing technology 121 8.1.3.2 Multiomics integration 122 8.1.3.3 Spatial genomics and transcriptomics 122 8.1.3.4 Gene editing technologies 122 8.2 TECHNOLOGY ROADMAP 123 8.3 PATENT ANALYSIS 123 8.3.1 METHODOLOGY 123 8.3.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE 124 8.3.3 LIST OF KEY PATENTS 125 8.4 FUTURE APPLICATIONS 125 8.5 IMPACT OF AI/GEN AI ON NEXT-GENERATION SEQUENCING MARKET 126 8.5.1 TOP USE CASES AND MARKET POTENTIAL 127 8.5.2 BEST PRACTICES IN AI-ENABLED NGS WORKFLOWS 128 8.5.3 CASE STUDIES OF AI IMPLEMENTATION IN NEXT-GENERATION SEQUENCING MARKET 128 8.5.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 128 8.5.5 CLIENTS’ READINESS TO ADOPT AI-INTEGRATED SEQUENCING SOLUTIONS IN NEXT-GENERATION SEQUENCING MARKET 129 9 NEXT-GENERATION SEQUENCING MARKET, BY OFFERING 130 9.1 INTRODUCTION 131 9.2 PRODUCTS 131 9.2.1 DEMAND FOR CONSUMABLES AND TECHNOLOGICAL ADVANCEMENTS TO PROPEL MARKET 131 9.3 SERVICES 134 9.3.1 SHIFT TOWARD SERVICE-BASED MODELS TO DRIVE MARKET 134 10 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY TYPE 138 10.1 INTRODUCTION 139 10.2 CONSUMABLES 139 10.2.1 LIBRARY PREPARATION KITS & REAGENTS 143 10.2.1.1 Strong demand and growing applications to ensure market growth 143 10.2.2 SEQUENCING KITS & REAGENTS 147 10.2.2.1 Focus on technological advancements to support market growth 147 10.2.3 OTHER CONSUMABLES 151   10.3 PLATFORMS 154 10.3.1 SEQUENCING PLATFORMS 157 10.3.1.1 Need for advanced technologies to decode genetic information to drive market 157 10.3.1.2 Illumina 160 10.3.1.2.1 NovaSeq Series (X/X Plus) 161 10.3.1.2.1.1 Next-generation ultra-high throughput sequencing to enable large-scale genomics 161 10.3.1.2.2 MiSeq/MiSeq i100 162 10.3.1.2.2.1 Compact sequencing platforms to enable rapid and targeted genomic analysis 162 10.3.1.2.3 NextSeq 1k/2K and 550 163 10.3.1.2.3.1 Mid-throughput sequencing systems to support diverse research and clinical applications 163 10.3.1.2.4 NovaSeq 6000 164 10.3.1.2.4.1 High-throughput sequencing platform to enable large-scale genomic studies 164 10.3.1.3 Thermo Fisher Scientific 165 10.3.1.4 PacBio 166 10.3.1.4.1 Revio 167 10.3.1.4.1.1 High-throughput long-read sequencing to support market growth 167 10.3.1.4.2 Sequel II/IIe 168 10.3.1.4.2.1 High-accuracy, long-read sequencing to support market growth 168 10.3.1.4.3 Vega Seq 169 10.3.1.4.3.1 Benchtop long-read sequencing platform to support market growth 169 10.3.1.5 Oxford Nanopore Technologies 170 10.3.1.6 Other sequencing platforms 170 10.3.2 LIBRARY PREPARATION PLATFORMS 171 10.3.2.1 Rising demand for sequencing in clinical applications to drive market 171 10.4 BIOINFORMATICS TOOLS 174 10.4.1 DATA ANALYSIS SOFTWARE & WORKBENCHES 178 10.4.1.1 Demand for genome analysis in clinical diagnostics to support market growth 178 10.4.2 DATA VISUALIZATION TOOLS 182 10.4.2.1 Rising demand for sequencing-based research to support market growth 182 10.4.3 OTHER BIOINFORMATICS TOOLS 185 11 NEXT-GENERATION SEQUENCING PLATFORMS MARKET, BY TECHNOLOGY 188 11.1 INTRODUCTION 189 11.2 SEQUENCING BY SYNTHESIS 190 11.2.1 HIGH, RAPID PRODUCTION OF BASE PAIRS TO SUPPORT ADOPTION 190   11.3 ION SEMICONDUCTOR SEQUENCING 194 11.3.1 SIMPLER WORKFLOW AND COST-EFFECTIVENESS TO SUPPORT MARKET GROWTH 194 11.4 SMRT SEQUENCING 198 11.4.1 FOCUS ON RAPID RESULTS AND LOWER SEQUENCING COSTS TO DRIVE MARKET 198 11.5 NANOPORE SEQUENCING 201 11.5.1 EMPHASIS ON DIRECT RNA SEQUENCING CAPABILITIES TO PROPEL DEMAND 201 11.6 OTHER SEQUENCING TECHNOLOGIES 205 12 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY WORKFLOW 209 12.1 INTRODUCTION 210 12.2 SEQUENCING 210 12.2.1 ABILITY TO ADDRESS COMPLEX GENOMIC REGIONS AND RESOLVE STRUCTURAL VARIATIONS TO DRIVE MARKET 210 12.3 PRESEQUENCING 214 12.3.1 INCREASED RESEARCH AND SUPPLY AGREEMENTS BETWEEN INDUSTRY PARTICIPANTS TO DRIVE MARKET 214 12.4 DATA ANALYSIS 218 12.4.1 RISE OF IN-HOUSE INSTALLATION OF BIOINFORMATICS INFRASTRUCTURE TO DRIVE MARKET 218 13 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY END USER 222 13.1 INTRODUCTION 223 13.2 ACADEMIC & RESEARCH INSTITUTES 223 13.2.1 RISING RESEARCH INTENSITY FOR GENOME RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH 223 13.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 227 13.3.1 RISING DEMAND FOR COMPREHENSIVE SEQUENCING DATA IN GENETIC RESEARCH TO DRIVE MARKET 227 13.4 CLINICAL & DIAGNOSTIC LABORATORIES 231 13.4.1 INCREASED APPLICATIONS IN DISEASE DIAGNOSTICS AND TREATMENT TO DRIVE MARKET GROWTH 231 13.5 OTHER END USERS 234 14 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE 238 14.1 INTRODUCTION 239 14.2 SEQUENCING SERVICES 239 14.2.1 EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS 243 14.2.1.1 Advancements in target enrichment technologies to drive market 243 14.2.2 RNA SEQUENCING SERVICES 247 14.2.2.1 Launch of RNA services and availability of diverse RNA bioinformatics tools to drive market 247   14.2.3 DE NOVO SEQUENCING SERVICES 250 14.2.3.1 Need for more accurate and faster characterization than traditional methods to drive market 250 14.2.4 CHIP SEQUENCING SERVICES 253 14.2.4.1 Surge in demand from academic and research institutes to drive market 253 14.2.5 WHOLE-GENOME SEQUENCING SERVICES 257 14.2.5.1 Technological advancements in next-generation sequencing products to drive market 257 14.2.6 METHYL SEQUENCING SERVICES 260 14.2.6.1 Large-scale adoption in cancer research to drive market 260 14.2.7 OTHER SEQUENCING SERVICES 264 14.3 PRESEQUENCING SERVICES 267 14.3.1 LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES 270 14.3.1.1 Development of advanced library preparation solutions to drive market 270 14.3.2 SAMPLE PREPARATION SERVICES 274 14.3.2.1 Applicability in oncology, infectious diseases, metagenomics, and epigenetics to drive market 274 14.3.3 QUALITY CONTROL SERVICES 277 14.3.3.1 Growing research activities using next-generation sequencing technology to drive market 277 14.4 BIOINFORMATICS & DATA ANALYSIS SERVICES 280 14.4.1 DATA ANALYSIS SERVICES 284 14.4.1.1 Increasing demand for precision and speed in genomics for clinical diagnosis to drive market 284 14.4.2 DATA VISUALIZATION & INTERPRETATION SERVICES 288 14.4.2.1 Rising demand for sequencing-based research to drive market 288 14.4.3 DATA STORAGE & MANAGEMENT SERVICES 291 14.4.3.1 Need for effective data management to drive market 291 14.5 NGS PLATFORM SERVICES 294 14.5.1 COMPLIANCE WITH STRINGENT QUALITY AND OPERATIONAL REQUIREMENTS TO DRIVE MARKET 294 15 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY WORKFLOW 298 15.1 INTRODUCTION 299 15.2 SEQUENCING 299 15.2.1 RISING DEMAND FOR SEQUENCING SERVICES AND APPLICATIONS IN CLINICAL DIAGNOSTICS TO SUPPORT MARKET GROWTH 299 15.3 PRESEQUENCING SERVICES 303 15.3.1 CUSTOM DEVELOPMENT OF SAMPLES FOR SEQUENCING TO BOOST MARKET GROWTH 303 15.4 DATA ANALYSIS SERVICES 306 15.4.1 RISING DEMAND FOR ADVANCED RESEARCH TO DRIVE MARKET 306 16 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER 310 16.1 INTRODUCTION 311 16.2 ACADEMIC & RESEARCH INSTITUTES 311 16.2.1 GROWING RESEARCH INTENSITY TO SUPPORT MARKET GROWTH 311 16.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 315 16.3.1 RISING DEMAND FOR COMPREHENSIVE GENETIC DATA TO DRIVE GROWTH 315 16.4 HOSPITALS & CLINICAL LABORATORIES 318 16.4.1 INCREASED APPLICATION IN NGS IN DISEASE DIAGNOSTICS AND TREATMENT TO DRIVE GROWTH 318 16.5 OTHER END USERS 322 17 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION 326 17.1 INTRODUCTION 327 17.2 DIAGNOSTICS 327 17.2.1 CANCER DIAGNOSTICS 331 17.2.1.1 Rising demand for targeted therapies to drive market 331 17.2.2 INFECTIOUS DISEASE DIAGNOSTICS 335 17.2.2.1 Rising demand for comprehensive genomic data in clinical diagnostics to propel growth 335 17.2.3 REPRODUCTIVE HEALTH DIAGNOSTICS 338 17.2.3.1 Focus on genetic disease diagnostics to drive growth 338 17.2.4 OTHER DIAGNOSTIC APPLICATIONS 342 17.3 DRUG DISCOVERY & DEVELOPMENT 345 17.3.1 PHARMACOGENOMICS 348 17.3.1.1 Rising use of NGS for understanding genomic variants in humans to drive growth 348 17.3.2 OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS 352 17.4 AGRICULTURE & ANIMAL RESEARCH 355 17.4.1 EMPHASIS ON IMPROVING CROP PRODUCTIVITY TO DRIVE ADOPTION OF NGS 355 17.5 OTHER APPLICATIONS 358 18 NEXT-GENERATION SEQUENCING MARKET, BY REGION 362 18.1 INTRODUCTION 363 18.2 NORTH AMERICA 363 18.2.1 US 372 18.2.1.1 Rapid growth and advancements to lead market 372 18.2.2 CANADA 379 18.2.2.1 Increasing government initiatives in sequencing research to boost market growth 379 18.3 EUROPE 386 18.3.1 GERMANY 393 18.3.1.1 Adoption of advanced sequencing technologies to drive market 393   18.3.2 UK 400 18.3.2.1 Strategic initiatives and funding for genomics research to support market growth 400 18.3.3 FRANCE 407 18.3.3.1 Increasing government investment in genomics research to drive growth 407 18.3.4 ITALY 414 18.3.4.1 Favorable funding scenario to drive adoption of advanced sequencing technology 414 18.3.5 SPAIN 421 18.3.5.1 Growing focus on advancements in personalized medicine to support market growth 421 18.3.6 NETHERLANDS 428 18.3.6.1 Well-established research infrastructure to sustain demand for NGS 428 18.3.7 REST OF EUROPE 435 18.4 ASIA PACIFIC 443 18.4.1 CHINA 451 18.4.1.1 Favorable regulatory reforms to drive market 451 18.4.2 JAPAN 458 18.4.2.1 Rising number of collaborations in NGS to drive market 458 18.4.3 INDIA 465 18.4.3.1 Government and private initiatives for genomics projects to propel market 465 18.4.4 AUSTRALIA 472 18.4.4.1 Increased genetic research in Australia to support market growth 472 18.4.5 SOUTH KOREA 479 18.4.5.1 Demand for advanced sequencing technologies to support market 479 18.4.6 REST OF ASIA PACIFIC 486 18.5 LATIN AMERICA 494 18.5.1 BRAZIL 501 18.5.1.1 Increased government investments in genomics advancements to drive market 501 18.5.2 MEXICO 507 18.5.2.1 Rising demand for chronic disease treatment to support growth 507 18.5.3 REST OF LATIN AMERICA 514 18.6 MIDDLE EAST 522 18.6.1 GCC COUNTRIES 529 18.6.1.1 Saudi Arabia 536 18.6.1.1.1 Growing healthcare expenditure in Saudi Arabia to boost market growth 536 18.6.1.2 UAE 543 18.6.1.2.1 Collaborations to advance genome sequencing and market growth 543 18.6.1.3 Rest of GCC countries 549 18.6.2 REST OF MIDDLE EAST 557 18.7 AFRICA 565 18.7.1 GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET 565 19 COMPETITIVE LANDSCAPE 574 19.1 INTRODUCTION 574 19.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 574 19.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NGS MARKET 574 19.3 REVENUE ANALYSIS, 2021–2025 576 19.4 MARKET SHARE ANALYSIS, 2025 577 19.5 BRAND/PRODUCT COMPARISON 580 19.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 581 19.6.1 STARS 581 19.6.2 EMERGING LEADERS 581 19.6.3 PERVASIVE PLAYERS 581 19.6.4 PARTICIPANTS 581 19.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 583 19.6.5.1 Company footprint 583 19.6.5.2 Region footprint 584 19.6.5.3 Offering footprint 585 19.6.5.4 Application footprint 586 19.6.5.5 Technology footprint 587 19.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 588 19.7.1 PROGRESSIVE COMPANIES 588 19.7.2 RESPONSIVE COMPANIES 588 19.7.3 DYNAMIC COMPANIES 588 19.7.4 STARTING BLOCKS 589 19.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 590 19.7.5.1 Detailed list of key startups/SMEs 590 19.7.5.2 Competitive benchmarking of startups/SMEs 591 19.8 COMPANY VALUATION & FINANCIAL METRICS 592 19.8.1 COMPANY VALUATION 592 19.8.2 FINANCIAL METRICS 592 19.9 COMPETITIVE SCENARIO 593 19.9.1 PRODUCT LAUNCHES 593 19.9.2 DEALS 594 19.9.3 EXPANSIONS 595   20 COMPANY PROFILES 596 20.1 KEY PLAYERS 596 20.1.1 ILLUMINA, INC. 596 20.1.1.1 Business overview 596 20.1.1.2 Products/Services offered 597 20.1.1.3 Recent developments 600 20.1.1.3.1 Product launches 600 20.1.1.3.2 Deals 601 20.1.1.4 MnM view 602 20.1.1.4.1 Key strengths 602 20.1.1.4.2 Strategic choices 602 20.1.1.4.3 Weaknesses and competitive threats 602 20.1.2 THERMO FISHER SCIENTIFIC INC. 603 20.1.2.1 Business overview 603 20.1.2.2 Products/Services offered 604 20.1.2.3 Recent developments 607 20.1.2.3.1 Product launches 607 20.1.2.3.2 Deals 608 20.1.2.3.3 Expansions 609 20.1.2.4 MnM view 609 20.1.2.4.1 Key strengths 609 20.1.2.4.2 Strategic choices 609 20.1.2.4.3 Weaknesses and competitive threats 609 20.1.3 AGILENT TECHNOLOGIES, INC. 610 20.1.3.1 Business overview 610 20.1.3.2 Products/Services offered 611 20.1.3.3 Recent developments 613 20.1.3.3.1 Deals 613 20.1.3.3.2 Expansions 614 20.1.3.4 MnM view 614 20.1.3.4.1 Key strengths 614 20.1.3.4.2 Strategic choices 614 20.1.3.4.3 Weaknesses and competitive threats 614 20.1.4 F. HOFFMANN-LA ROCHE LTD. 615 20.1.4.1 Business overview 615 20.1.4.2 Products/Services offered 616 20.1.4.3 Recent developments 618 20.1.4.3.1 Product launches 618 20.1.4.3.2 Deals 618 20.1.4.3.3 Other developments 619 20.1.4.4 MnM view 619 20.1.4.4.1 Key strengths 619 20.1.4.4.2 Strategic choices 619 20.1.4.4.3 Weaknesses and competitive threats 619 20.1.5 QIAGEN 620 20.1.5.1 Business overview 620 20.1.5.2 Products/services offered 621 20.1.5.3 Recent developments 623 20.1.5.3.1 Deals 624 20.1.5.3.2 Expansions 625 20.1.5.4 MnM view 626 20.1.5.4.1 Key strengths 626 20.1.5.4.2 Strategic choices 626 20.1.5.4.3 Weaknesses and competitive threats 626 20.1.6 DANAHER CORPORATION 627 20.1.6.1 Business overview 627 20.1.6.2 Products/services offered 628 20.1.6.3 Recent developments 630 20.1.6.3.1 Product launches 630 20.1.6.3.2 Deals 631 20.1.6.3.3 Expansions 631 20.1.7 REVVITY 632 20.1.7.1 Business overview 632 20.1.7.2 Products/Services offered 633 20.1.7.3 Recent developments 635 20.1.7.3.1 Product launches 635 20.1.7.3.2 Deals 635 20.1.7.3.3 Expansions 636 20.1.8 EUROFINS SCIENTIFIC 637 20.1.8.1 Business overview 637 20.1.8.2 Products/services offered 638 20.1.8.3 Recent developments 638 20.1.8.3.1 Deals 638 20.1.9 PACBIO 639 20.1.9.1 Business overview 639 20.1.9.2 Products/Services offered 640 20.1.9.3 Recent developments 643 20.1.9.3.1 Product launches 643 20.1.9.3.2 Deals 643 20.1.9.3.3 Expansions 644 20.1.10 OXFORD NANOPORE TECHNOLOGIES PLC 645 20.1.10.1 Business overview 645 20.1.10.2 Products/Services offered 646 20.1.10.3 Recent developments 648 20.1.10.3.1 Deals 648 20.1.10.3.2 Expansions 649 20.1.11 TAKARA BIO INC. 650 20.1.11.1 Business overview 650 20.1.11.2 Products/Services offered 651 20.1.11.3 Recent developments 653 20.1.11.3.1 Deals 653 20.1.12 BGI GROUP 654 20.1.12.1 Business overview 654 20.1.12.2 Products/Services offered 654 20.1.13 BD 658 20.1.13.1 Business overview 658 20.1.13.2 Products/Services offered 659 20.1.13.3 Recent developments 660 20.1.13.3.1 Product launches 660 20.1.14 10X GENOMICS 661 20.1.14.1 Business overview 661 20.1.14.2 Products/Services offered 662 20.1.15 PROMEGA CORPORATION 665 20.1.15.1 Business overview 665 20.1.15.2 Products/Services offered 665 20.1.16 LGC LIMITED 666 20.1.16.1 Business overview 666 20.1.16.2 Products/Services offered 667 20.1.16.3 Recent developments 668 20.1.16.3.1 Deals 668 20.1.17 WUXI BIOLOGICS 669 20.1.17.1 Business overview 669 20.1.17.2 Products/Services offered 670 20.1.18 TECAN TRADING AG 671 20.1.18.1 Business overview 671 20.1.18.2 Products/Services offered 672 20.1.18.3 Recent developments 673 20.1.18.3.1 Deals 673 20.1.19 TWIST BIOSCIENCE 674 20.1.19.1 Business overview 674 20.1.19.2 Products/Services offered 675 20.1.19.3 Recent developments 676 20.1.19.3.1 Product launches 676 20.1.19.3.2 Deals 677   20.1.20 AZENTA US INC. 678 20.1.20.1 Business overview 678 20.1.20.2 Products/Services offered 679 20.1.20.3 Recent developments 680 20.1.20.3.1 Deals 680 20.2 OTHER PLAYERS 681 20.2.1 MGI TECH CO. LTD. 681 20.2.2 NOVOGENE CO., LTD. 683 20.2.3 NEW ENGLAND BIOLABS 684 20.2.4 GENSCRIPT 685 20.2.5 PSOMAGEN 685 20.2.6 ZYMO RESEARCH CORPORATION 686 20.2.7 HAMILTON COMPANY 687 20.2.8 NEOGENOMICS LABORATORIES 688 20.2.9 FULGENT GENETICS 689 20.2.10 SD BIOSENSOR, INC. 690 21 RESEARCH METHODOLOGY 691 21.1 RESEARCH DATA 691 21.1.1 SECONDARY DATA 691 21.1.1.1 Key data from secondary sources 691 21.1.2 PRIMARY DATA 692 21.1.2.1 Key data from primary sources 692 21.1.2.2 Key primary participants 693 21.1.2.3 Breakdown of primary interviews 693 21.1.2.4 Key industry insights 694 21.2 MARKET SIZE ESTIMATION 695 21.2.1 GLOBAL NEXT-GENERATION SEQUENCING MARKET ESTIMATION, 2025 695 21.2.2 SEGMENTAL MARKET SIZE ESTIMATION 697 21.3 MARKET GROWTH RATE PROJECTIONS 699 21.4 DATA TRIANGULATION 701 21.5 FACTOR ANALYSIS 702 21.6 RESEARCH ASSUMPTIONS 702 21.7 RESEARCH LIMITATIONS AND RISK ASSESSMENT 703 22 APPENDIX 705 22.1 DISCUSSION GUIDE 705 22.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 711 22.3 CUSTOMIZATION OPTIONS 713 22.4 RELATED REPORTS 713 22.5 AUTHOR DETAILS 714
圖表清單 List of Tables & Figures
TABLE 1 NEXT-GENERATION SEQUENCING MARKET: INCLUSIONS & EXCLUSIONS 60 TABLE 2 IMPACT OF MARKET DYNAMICS 72 TABLE 3 NEXT-GENERATION SEQUENCING MARKET: PORTER’S FIVE FORCES 78 TABLE 4 NEXT-GENERATION SEQUENCING MARKET: ROLE OF PLAYERS IN ECOSYSTEM 85 TABLE 5 AVERAGE SELLING PRICE TREND OF PLATFORMS, BY KEY PLAYER, 2023–2025 (USD) 86 TABLE 6 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2023–2025 (USD) 87 TABLE 7 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2025 (USD) 88 TABLE 8 AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025 (USD) 89 TABLE 9 IMPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 91 TABLE 10 IMPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (TONS) 92 TABLE 11 EXPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 93 TABLE 12 EXPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (TONS) 94 TABLE 13 IMPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 95 TABLE 14 IMPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (TONS) 96 TABLE 15 EXPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 97 TABLE 16 EXPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (TONS) 98 TABLE 17 NEXT-GENERATION SEQUENCING MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2026–MARCH 2027 99 TABLE 18 RECIPROCAL TARIFF RATES ADJUSTED BY US 103 TABLE 19 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES 104 TABLE 20 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE 108 TABLE 21 KEY BUYING CRITERIA FOR PRODUCTS, BY END USER 108 TABLE 22 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111 TABLE 23 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111 TABLE 24 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 112 TABLE 25 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113 TABLE 26 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2015–2025 124 TABLE 27 KEY PATENTS, 2023–2025 125 TABLE 28 CASE STUDIES OF AI IMPLEMENTATION IN NEXT-GENERATION SEQUENCING MARKET 128 TABLE 29 CLIENT’S READINESS TO ADOPT AI-INTEGRATED SEQUENCING SOLUTIONS IN NEXT-GENERATION SEQUENCING MARKET 129 TABLE 30 NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 131 TABLE 31 NGS PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION) 132 TABLE 32 NORTH AMERICA: NGS PRODUCTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 33 EUROPE: NGS PRODUCTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 132 TABLE 34 ASIA PACIFIC: NGS PRODUCTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 133 TABLE 35 LATIN AMERICA: NGS PRODUCTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 133 TABLE 36 MIDDLE EAST: NGS PRODUCTS MARKET, BY REGION, 2024–2031 (USD MILLION) 133 TABLE 37 GCC COUNTRIES: NGS PRODUCTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 134 TABLE 38 NGS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 135 TABLE 39 NORTH AMERICA: NGS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135 TABLE 40 EUROPE: NGS SERVICES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 135 TABLE 41 ASIA PACIFIC: NGS SERVICES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 136 TABLE 42 LATIN AMERICA: NGS SERVICES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 136 TABLE 43 MIDDLE EAST: NGS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 136 TABLE 44 GCC COUNTRIES: NGS SERVICES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 137 TABLE 45 NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 139 TABLE 46 NGS CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 140 TABLE 47 NORTH AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 140 TABLE 48 EUROPE: NGS CONSUMABLES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 141 TABLE 49 ASIA PACIFIC: NGS CONSUMABLES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 141 TABLE 50 LATIN AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 142 TABLE 51 MIDDLE EAST: NGS CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 142 TABLE 52 GCC COUNTRIES: NGS CONSUMABLES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 142 TABLE 53 NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 143 TABLE 54 LIBRARY PREPARATION KITS & REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 144 TABLE 55 NORTH AMERICA: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 56 EUROPE: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 145 TABLE 57 ASIA PACIFIC: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 146 TABLE 58 LATIN AMERICA: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 146 TABLE 59 MIDDLE EAST: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY REGION/REGION, 2024–2031 (USD MILLION) 146 TABLE 60 GCC COUNTRIES: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 147 TABLE 61 SEQUENCING KITS & REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 148 TABLE 62 NORTH AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148 TABLE 63 EUROPE: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 149 TABLE 64 ASIA PACIFIC: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 149 TABLE 65 LATIN AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 150 TABLE 66 MIDDLE EAST: SEQUENCING KITS & REAGENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 150 TABLE 67 GCC COUNTRIES: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 150 TABLE 68 OTHER CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 151 TABLE 69 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 70 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 152 TABLE 71 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 152 TABLE 72 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 153 TABLE 73 MIDDLE EAST: OTHER CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 153 TABLE 74 GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 153 TABLE 75 NGS PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION) 154 TABLE 76 NORTH AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 77 EUROPE: NGS PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 155 TABLE 78 ASIA PACIFIC: NGS PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 155 TABLE 79 LATIN AMERICA: NGS PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 156 TABLE 80 MIDDLE EAST: NGS PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION) 156 TABLE 81 GCC COUNTRIES: NGS PLATFORMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 156 TABLE 82 NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 157 TABLE 83 SEQUENCING PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION) 157 TABLE 84 NORTH AMERICA: SEQUENCING PLATFORMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 85 EUROPE: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 158 TABLE 86 ASIA PACIFIC: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 159 TABLE 87 LATIN AMERICA: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 159 TABLE 88 MIDDLE EAST: SEQUENCING PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION) 159 TABLE 89 GCC COUNTRIES: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 160 TABLE 90 SEQUENCING PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 160 TABLE 91 ILLUMINA SEQUENCING PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 161 TABLE 92 ILLUMINA SEQUENCING PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION) 161 TABLE 93 NOVASEQ (X/X PLUS) SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 162 TABLE 94 MISEQ/MISEQ I100 SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 163 TABLE 95 NEXTSEQ 1K/2K AND 550 SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 164 TABLE 96 NOVASEQ 6000 SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 165 TABLE 97 THERMO FISHER SCIENTIFIC SEQUENCING PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION) 166 TABLE 98 PACBIO SEQUENCING PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION) 166 TABLE 99 OXFORD NANOPORE TECHNOLOGIES SEQUENCING PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION) 170 TABLE 100 LIBRARY PREPARATION PLATFORMS MARKET, BY REGION, 2024–2031 (USD MILLION) 171 TABLE 101 NORTH AMERICA: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 102 EUROPE: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 172 TABLE 103 ASIA PACIFIC: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 173 TABLE 104 LATIN AMERICA: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 173 TABLE 105 MIDDLE EAST: LIBRARY PREPARATION PLATFORMS MARKET, BY REGION/REGION, 2024–2031 (USD MILLION) 173 TABLE 106 GCC COUNTRIES: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 174 TABLE 107 NGS BIOINFORMATICS TOOLS MARKET, BY REGION, 2024–2031 (USD MILLION) 175 TABLE 108 NORTH AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 109 EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 176 TABLE 110 ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 176 TABLE 111 LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 177 TABLE 112 MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY REGION, 2024–2031 (USD MILLION) 177 TABLE 113 GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 177 TABLE 114 NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 177 TABLE 115 DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY REGION, 2024–2031 (USD MILLION) 179 TABLE 116 NORTH AMERICA: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 117 EUROPE: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 180 TABLE 118 ASIA PACIFIC: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 180 TABLE 119 LATIN AMERICA: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 181 TABLE 120 MIDDLE EAST: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY REGION, 2024–2031 (USD MILLION) 181 TABLE 121 GCC COUNTRIES: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 181 TABLE 122 DATA VISUALIZATION TOOLS MARKET, BY REGION, 2024–2031 (USD MILLION) 182 TABLE 123 NORTH AMERICA: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 182 TABLE 124 EUROPE: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 183 TABLE 125 ASIA PACIFIC: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 183 TABLE 126 LATIN AMERICA: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 184 TABLE 127 MIDDLE EAST: DATA VISUALIZATION TOOLS MARKET, BY REGION, 2024–2031 (USD MILLION) 184 TABLE 128 GCC COUNTRIES: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 184 TABLE 129 OTHER BIOINFORMATICS TOOLS MARKET, BY REGION, 2024–2031 (USD MILLION) 185 TABLE 130 NORTH AMERICA: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 185 TABLE 131 EUROPE: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 186 TABLE 132 ASIA PACIFIC: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 186 TABLE 133 LATIN AMERICA: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 187 TABLE 134 MIDDLE EAST: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 187 TABLE 135 GCC COUNTRIES: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 187 TABLE 136 NGS TECHNOLOGIES, BY COMPANY 189 TABLE 137 NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 190 TABLE 138 NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 2024–2031 (USD MILLION) 191 TABLE 139 NORTH AMERICA: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2024–2031 (USD MILLION) 191 TABLE 140 EUROPE: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 192 TABLE 141 ASIA PACIFIC: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 192 TABLE 142 LATIN AMERICA: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 193 TABLE 143 MIDDLE EAST: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 2024–2031 (USD MILLION) 193 TABLE 144 GCC COUNTRIES: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 193 TABLE 145 NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2024–2031 (USD MILLION) 195 TABLE 146 NORTH AMERICA: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2024–2031 (USD MILLION) 195 TABLE 147 EUROPE: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 196 TABLE 148 ASIA PACIFIC: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 196 TABLE 149 LATIN AMERICA: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 197 TABLE 150 MIDDLE EAST: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2024–2031 (USD MILLION) 197 TABLE 151 GCC COUNTRIES: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 197 TABLE 152 NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY REGION, 2024–2031 (USD MILLION) 198 TABLE 153 NORTH AMERICA: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2024–2031 (USD MILLION) 199 TABLE 154 EUROPE: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 199 TABLE 155 ASIA PACIFIC: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 200 TABLE 156 LATIN AMERICA: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 200 TABLE 157 MIDDLE EAST: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY REGION, 2024–2031 (USD MILLION) 201 TABLE 158 GCC COUNTRIES: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 201 TABLE 159 NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY REGION, 2024–2031 (USD MILLION) 202 TABLE 160 NORTH AMERICA: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2024–2031 (USD MILLION) 203 TABLE 161 EUROPE: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 203 TABLE 162 ASIA PACIFIC: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 204 TABLE 163 LATIN AMERICA: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 204 TABLE 164 MIDDLE EAST: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY REGION, 2024–2031 (USD MILLION) 205 TABLE 165 GCC COUNTRIES: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 205 TABLE 166 NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION) 206 TABLE 167 NORTH AMERICA: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 206 TABLE 168 EUROPE: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 207 TABLE 169 ASIA PACIFIC: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 207 TABLE 170 LATIN AMERICA: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 208 TABLE 171 MIDDLE EAST: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION) 208 TABLE 172 GCC COUNTRIES: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 208 TABLE 173 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 210 TABLE 174 NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY REGION, 2024–2031 (USD MILLION) 211 TABLE 175 NORTH AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 211 TABLE 176 EUROPE: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 212 TABLE 177 ASIA PACIFIC: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 212 TABLE 178 LATIN AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 213 TABLE 179 MIDDLE EAST: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY REGION, 2024–2031 (USD MILLION) 213 TABLE 180 GCC COUNTRIES: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 213 TABLE 181 NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY REGION, 2024–2031 (USD MILLION) 215 TABLE 182 NORTH AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 215 TABLE 183 EUROPE: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 216 TABLE 184 ASIA PACIFIC: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 216 TABLE 185 LATIN AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 217 TABLE 186 MIDDLE EAST: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY REGION, 2024–2031 (USD MILLION) 217 TABLE 187 GCC COUNTRIES: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 217 TABLE 188 NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2024–2031 (USD MILLION) 219 TABLE 189 NORTH AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 219 TABLE 190 EUROPE: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 220 TABLE 191 ASIA PACIFIC: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 220 TABLE 192 LATIN AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 221 TABLE 193 MIDDLE EAST: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2024–2031 (USD MILLION) 221 TABLE 194 GCC COUNTRIES: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024–2031 (USD MILLION) 221 TABLE 195 NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 223 TABLE 196 NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 224 TABLE 197 NORTH AMERICA: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 224 TABLE 198 EUROPE: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 225 TABLE 199 ASIA PACIFIC: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 225 TABLE 200 LATIN AMERICA: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 226 TABLE 201 MIDDLE EAST: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 226 TABLE 202 GCC COUNTRIES: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 226 TABLE 203 NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 228 TABLE 204 NORTH AMERICA: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 228 TABLE 205 EUROPE: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 229 TABLE 206 ASIA PACIFIC: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 229 TABLE 207 LATIN AMERICA: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 230 TABLE 208 MIDDLE EAST: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 230 TABLE 209 GCC COUNTRIES: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 230 TABLE 210 NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 231 TABLE 211 NORTH AMERICA: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 232 TABLE 212 EUROPE: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 232 TABLE 213 ASIA PACIFIC: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 233 TABLE 214 LATIN AMERICA: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 233 TABLE 215 MIDDLE EAST: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 233 TABLE 216 GCC COUNTRIES: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 234 TABLE 217 NGS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 235 TABLE 218 NORTH AMERICA: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 235 TABLE 219 EUROPE: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 236 TABLE 220 ASIA PACIFIC: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 236 TABLE 221 LATIN AMERICA: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 237 TABLE 222 MIDDLE EAST: NGS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 237 TABLE 223 GCC COUNTRIES: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 237 TABLE 224 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 239 TABLE 225 SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 240 TABLE 226 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 240 TABLE 227 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 241 TABLE 228 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 241 TABLE 229 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 242 TABLE 230 MIDDLE EAST: SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 242 TABLE 231 GCC COUNTRIES: SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 242 TABLE 232 SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 243 TABLE 233 EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY REGION, 2024–2031 (USD MILLION) 244 TABLE 234 NORTH AMERICA: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 244 TABLE 235 EUROPE: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 245 TABLE 236 ASIA PACIFIC: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 245 TABLE 237 LATIN AMERICA: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 246 TABLE 238 MIDDLE EAST: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY REGION, 2024–2031 (USD MILLION) 246 TABLE 239 GCC COUNTRIES: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 246 TABLE 240 RNA SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 247 TABLE 241 NORTH AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 247 TABLE 242 EUROPE: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 248 TABLE 243 ASIA PACIFIC: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 248 TABLE 244 LATIN AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 249 TABLE 245 MIDDLE EAST: RNA SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 249 TABLE 246 GCC COUNTRIES: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 249 TABLE 247 DE NOVO SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 250 TABLE 248 NORTH AMERICA: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 251 TABLE 249 EUROPE: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 251 TABLE 250 ASIA PACIFIC: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 252 TABLE 251 LATIN AMERICA: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 252 TABLE 252 MIDDLE EAST: DE NOVO SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 252 TABLE 253 GCC COUNTRIES: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 253 TABLE 254 CHIP SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 254 TABLE 255 NORTH AMERICA: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 254 TABLE 256 EUROPE: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 255 TABLE 257 ASIA PACIFIC: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 255 TABLE 258 LATIN AMERICA: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 256 TABLE 259 MIDDLE EAST: CHIP SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 256 TABLE 260 GCC COUNTRIES: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 256 TABLE 261 WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 257 TABLE 262 NORTH AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 258 TABLE 263 EUROPE: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 258 TABLE 264 ASIA PACIFIC: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 259 TABLE 265 LATIN AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 259 TABLE 266 MIDDLE EAST: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 259 TABLE 267 GCC COUNTRIES: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 260 TABLE 268 METHYL SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 261 TABLE 269 NORTH AMERICA: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 261 TABLE 270 EUROPE: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 262 TABLE 271 ASIA PACIFIC: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 262 TABLE 272 LATIN AMERICA: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 263 TABLE 273 MIDDLE EAST: METHYL SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 263 TABLE 274 GCC COUNTRIES: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 263 TABLE 275 OTHER SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 264 TABLE 276 NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 265 TABLE 277 EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 265 TABLE 278 ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 266 TABLE 279 LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 266 TABLE 280 MIDDLE EAST: OTHER SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 266 TABLE 281 GCC COUNTRIES: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 267 TABLE 282 PRESEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 267 TABLE 283 NORTH AMERICA: PRESEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 268 TABLE 284 EUROPE: PRESEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 268 TABLE 285 ASIA PACIFIC: PRESEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 269 TABLE 286 LATIN AMERICA: PRESEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 269 TABLE 287 MIDDLE EAST: PRESEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 269 TABLE 288 GCC COUNTRIES: PRESEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 270 TABLE 289 PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 270 TABLE 290 LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 271 TABLE 291 NORTH AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 271 TABLE 292 EUROPE: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 272 TABLE 293 ASIA PACIFIC: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 272 TABLE 294 LATIN AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 273 TABLE 295 MIDDLE EAST: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 273 TABLE 296 GCC COUNTRIES: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 273 TABLE 297 SAMPLE PREPARATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 274 TABLE 298 NORTH AMERICA: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 275 TABLE 299 EUROPE: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 275 TABLE 300 ASIA PACIFIC: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 276 TABLE 301 LATIN AMERICA: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 276 TABLE 302 MIDDLE EAST: SAMPLE PREPARATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 276 TABLE 303 GCC COUNTRIES: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 277 TABLE 304 QUALITY CONTROL SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 277 TABLE 305 NORTH AMERICA: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 278 TABLE 306 EUROPE: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 278 TABLE 307 ASIA PACIFIC: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 279 TABLE 308 LATIN AMERICA: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 279 TABLE 309 MIDDLE EAST: QUALITY CONTROL SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 279 TABLE 310 GCC COUNTRIES: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 280 TABLE 311 BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 281 TABLE 312 NORTH AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 281 TABLE 313 EUROPE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 282 TABLE 314 ASIA PACIFIC: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 282 TABLE 315 LATIN AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 283 TABLE 316 MIDDLE EAST: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 283 TABLE 317 GCC COUNTRIES: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 283 TABLE 318 BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 284 TABLE 319 DATA ANALYSIS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 285 TABLE 320 NORTH AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 285 TABLE 321 EUROPE: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 286 TABLE 322 ASIA PACIFIC: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 286 TABLE 323 LATIN AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 287 TABLE 324 MIDDLE EAST: DATA ANALYSIS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 287 TABLE 325 GCC COUNTRIES: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 287 TABLE 326 DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 288 TABLE 327 NORTH AMERICA: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 289 TABLE 328 EUROPE: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 289 TABLE 329 ASIA PACIFIC: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 290 TABLE 330 LATIN AMERICA: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 290 TABLE 331 MIDDLE EAST: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 290 TABLE 332 GCC COUNTRIES: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 291 TABLE 333 DATA STORAGE & MANAGEMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 291 TABLE 334 NORTH AMERICA: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 292 TABLE 335 EUROPE: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 292 TABLE 336 ASIA PACIFIC: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 293 TABLE 337 LATIN AMERICA: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 293 TABLE 338 MIDDLE EAST: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 293 TABLE 339 GCC COUNTRIES: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 294 TABLE 340 NGS PLATFORM SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 294 TABLE 341 NORTH AMERICA: NGS PLATFORM SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 295 TABLE 342 EUROPE: NGS PLATFORM SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 295 TABLE 343 ASIA PACIFIC: NGS PLATFORM SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 296 TABLE 344 LATIN AMERICA: NGS PLATFORM SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 296 TABLE 345 MIDDLE EAST: NGS PLATFORM SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 296 TABLE 346 GCC COUNTRIES: NGS PLATFORM SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 297 TABLE 347 NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 299 TABLE 348 NGS SERVICES MARKET FOR SEQUENCING, BY REGION, 2024–2031 (USD MILLION) 300 TABLE 349 NORTH AMERICA: NGS SERVICES MARKET FOR SEQUENCING, BY COUNTRY, 2024–2031 (USD MILLION) 300 TABLE 350 EUROPE: NGS SERVICES MARKET FOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 301 TABLE 351 ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 301 TABLE 352 LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 302 TABLE 353 MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING, BY REGION, 2024–2031 (USD MILLION) 302 TABLE 354 GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 302 TABLE 355 NGS SERVICES MARKET FOR PRESEQUENCING, BY REGION, 2024–2031 (USD MILLION) 303 TABLE 356 NORTH AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING, BY COUNTRY, 2024–2031 (USD MILLION) 304 TABLE 357 EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 304 TABLE 358 ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 305 TABLE 359 LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 305 TABLE 360 MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING, BY REGION, 2024–2031 (USD MILLION) 306 TABLE 361 GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 306 TABLE 362 NGS SERVICES MARKET FOR DATA ANALYSIS, BY REGION, 2024–2031 (USD MILLION) 307 TABLE 363 NORTH AMERICA: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 307 TABLE 364 EUROPE: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 308 TABLE 365 ASIA PACIFIC: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 308 TABLE 366 LATIN AMERICA: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 309 TABLE 367 MIDDLE EAST: NGS SERVICES MARKET FOR DATA ANALYSIS, BY REGION, 2024–2031 (USD MILLION) 309 TABLE 368 GCC COUNTRIES: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 309 TABLE 369 NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 311 TABLE 370 NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 312 TABLE 371 NORTH AMERICA: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 312 TABLE 372 EUROPE: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 313 TABLE 373 ASIA PACIFIC: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 313 TABLE 374 LATIN AMERICA: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 314 TABLE 375 MIDDLE EAST: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 314 TABLE 376 GCC COUNTRIES: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 314 TABLE 377 NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 315 TABLE 378 NORTH AMERICA: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 316 TABLE 379 EUROPE: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 316 TABLE 380 ASIA PACIFIC: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 317 TABLE 381 LATIN AMERICA: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 317 TABLE 382 MIDDLE EAST: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 317 TABLE 383 GCC COUNTRIES: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 318 TABLE 384 NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 319 TABLE 385 NORTH AMERICA: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 319 TABLE 386 EUROPE: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 320 TABLE 387 ASIA PACIFIC: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 320 TABLE 388 LATIN AMERICA: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 321 TABLE 389 MIDDLE EAST: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 321 TABLE 390 GCC COUNTRIES: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY/REGION 2024–2031 (USD MILLION) 321 TABLE 391 NGS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 322 TABLE 392 NORTH AMERICA: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 323 TABLE 393 EUROPE: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 323 TABLE 394 ASIA PACIFIC: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 324 TABLE 395 LATIN AMERICA: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 324 TABLE 396 MIDDLE EAST: NGS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 324 TABLE 397 GCC COUNTRIES: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 325 TABLE 398 NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 327 TABLE 399 NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 328 TABLE 400 NORTH AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 328 TABLE 401 EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 329 TABLE 402 ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 329 TABLE 403 LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 330 TABLE 404 MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 330 TABLE 405 GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 330 TABLE 406 NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 331 TABLE 407 FUNDING AND GRANTS FOR CANCER RESEARCH, BY TYPE (AS OF JANUARY 2023) 331 TABLE 408 CANCER DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 332 TABLE 409 NORTH AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 333 TABLE 410 EUROPE: CANCER DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 333 TABLE 411 ASIA PACIFIC: CANCER DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 334 TABLE 412 LATIN AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 334 TABLE 413 MIDDLE EAST: CANCER DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 334 TABLE 414 GCC COUNTRIES: CANCER DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 335 TABLE 415 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 335 TABLE 416 NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 336 TABLE 417 EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 336 TABLE 418 ASIA PACIFIC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 337 TABLE 419 LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 337 TABLE 420 MIDDLE EAST: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 337 TABLE 421 GCC COUNTRIES: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 338 TABLE 422 REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 339 TABLE 423 NORTH AMERICA: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 339 TABLE 424 EUROPE: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 340 TABLE 425 ASIA PACIFIC: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 340 TABLE 426 LATIN AMERICA: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 341 TABLE 427 MIDDLE EAST: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 341 TABLE 428 GCC COUNTRIES: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 341 TABLE 429 OTHER DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION) 342 TABLE 430 NORTH AMERICA: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 342 TABLE 431 EUROPE: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 343 TABLE 432 ASIA PACIFIC: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 343 TABLE 433 LATIN AMERICA: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 344 TABLE 434 MIDDLE EAST: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION) 344 TABLE 435 GCC COUNTRIES: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 344 TABLE 436 NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 345 TABLE 437 NORTH AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 346 TABLE 438 EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 346 TABLE 439 ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 347 TABLE 440 LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 347 TABLE 441 MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 347 TABLE 442 GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 348 TABLE 443 NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 348 TABLE 444 PHARMACOGENOMICS MARKET, BY REGION, 2024–2031 (USD MILLION) 349 TABLE 445 NORTH AMERICA: PHARMACOGENOMICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 349 TABLE 446 EUROPE: PHARMACOGENOMICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 350 TABLE 447 ASIA PACIFIC: PHARMACOGENOMICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 350 TABLE 448 LATIN AMERICA: PHARMACOGENOMICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 351 TABLE 449 MIDDLE EAST: PHARMACOGENOMICS MARKET, BY REGION, 2024–2031 (USD MILLION) 351 TABLE 450 GCC COUNTRIES: PHARMACOGENOMICS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 351 TABLE 451 OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION) 352 TABLE 452 NORTH AMERICA: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 352 TABLE 453 EUROPE: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 353 TABLE 454 ASIA PACIFIC: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 353 TABLE 455 LATIN AMERICA: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 354 TABLE 456 MIDDLE EAST: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION) 354 TABLE 457 GCC COUNTRIES: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 354 TABLE 458 AGRICULTURE & ANIMAL RESEARCH MARKET, BY REGION, 2024–2031 (USD MILLION) 355 TABLE 459 NORTH AMERICA: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 356 TABLE 460 EUROPE: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 356 TABLE 461 ASIA PACIFIC: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 357 TABLE 462 LATIN AMERICA: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 357 TABLE 463 MIDDLE EAST: AGRICULTURE & ANIMAL RESEARCH MARKET, BY REGION, 2024–2031 (USD MILLION) 357 TABLE 464 GCC COUNTRIES: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 358 TABLE 465 OTHER APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION) 358 TABLE 466 NORTH AMERICA: OTHER APPLICATIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 359 TABLE 467 EUROPE: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 359 TABLE 468 ASIA PACIFIC: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 360 TABLE 469 LATIN AMERICA: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 360 TABLE 470 MIDDLE EAST: OTHER APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION) 360 TABLE 471 GCC COUNTRIES: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 361 TABLE 472 NGS MARKET, BY REGION, 2024–2031 (USD MILLION) 363 TABLE 473 NORTH AMERICA: NGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 364 TABLE 474 NORTH AMERICA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 365 TABLE 475 NORTH AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 365 TABLE 476 NORTH AMERICA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 365 TABLE 477 NORTH AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 366 TABLE 478 NORTH AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 366 TABLE 479 NORTH AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 367 TABLE 480 NORTH AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 367 TABLE 481 NORTH AMERICA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 368 TABLE 482 NORTH AMERICA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 368 TABLE 483 NORTH AMERICA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 369 TABLE 484 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 369 TABLE 485 NORTH AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 370 TABLE 486 NORTH AMERICA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 370 TABLE 487 NORTH AMERICA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 370 TABLE 488 NORTH AMERICA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 371 TABLE 489 NORTH AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 371 TABLE 490 NORTH AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 372 TABLE 491 US: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 373 TABLE 492 US: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 373 TABLE 493 US: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 373 TABLE 494 US: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 374 TABLE 495 US: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 374 TABLE 496 US: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 374 TABLE 497 US: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 375 TABLE 498 US: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 375 TABLE 499 US: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 375 TABLE 500 US: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 376 TABLE 501 US: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 376 TABLE 502 US: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 377 TABLE 503 US: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 377 TABLE 504 US: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 377 TABLE 505 US: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 378 TABLE 506 US: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 378 TABLE 507 US: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 379 TABLE 508 CANADA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 380 TABLE 509 CANADA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 380 TABLE 510 CANADA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 380 TABLE 511 CANADA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 381 TABLE 512 CANADA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 381 TABLE 513 CANADA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 381 TABLE 514 CANADA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 382 TABLE 515 CANADA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 382 TABLE 516 CANADA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 382 TABLE 517 CANADA: PRESEQUENCING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 383 TABLE 518 CANADA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 383 TABLE 519 CANADA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 384 TABLE 520 CANADA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 384 TABLE 521 CANADA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 384 TABLE 522 CANADA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 385 TABLE 523 CANADA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 385 TABLE 524 CANADA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 386 TABLE 525 EUROPE: NGS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 386 TABLE 526 EUROPE: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 387 TABLE 527 EUROPE: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 387 TABLE 528 EUROPE: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 387 TABLE 529 EUROPE: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 388 TABLE 530 EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 388 TABLE 531 EUROPE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 388 TABLE 532 EUROPE: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 389 TABLE 533 EUROPE: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 389 TABLE 534 EUROPE: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 389 TABLE 535 EUROPE: PRESEQUENCING SERVICES, BY TYPE, 2024–2031 (USD MILLION) 390 TABLE 536 EUROPE: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 390 TABLE 537 EUROPE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 391 TABLE 538 EUROPE: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 391 TABLE 539 EUROPE: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 391 TABLE 540 EUROPE: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 392 TABLE 541 EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 392 TABLE 542 EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 393 TABLE 543 GERMANY: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 394 TABLE 544 GERMANY: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 394 TABLE 545 GERMANY: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 394 TABLE 546 GERMANY: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 395 TABLE 547 GERMANY: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 395 TABLE 548 GERMANY: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 395 TABLE 549 GERMANY: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 396 TABLE 550 GERMANY: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 396 TABLE 551 GERMANY: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 396 TABLE 552 GERMANY: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 397 TABLE 553 GERMANY: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 397 TABLE 554 GERMANY: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 398 TABLE 555 GERMANY: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 398 TABLE 556 GERMANY: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 398 TABLE 557 GERMANY: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 399 TABLE 558 GERMANY: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 399 TABLE 559 GERMANY: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 400 TABLE 560 UK: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 401 TABLE 561 UK: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 401 TABLE 562 UK: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 401 TABLE 563 UK: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 402 TABLE 564 UK: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 402 TABLE 565 UK: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 402 TABLE 566 UK: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 403 TABLE 567 UK: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 403 TABLE 568 UK: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 403 TABLE 569 UK: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 404 TABLE 570 UK: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 404 TABLE 571 UK: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 405 TABLE 572 UK: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 405 TABLE 573 UK: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 405 TABLE 574 UK: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 406 TABLE 575 UK: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 406 TABLE 576 UK: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 407 TABLE 577 FRANCE: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 408 TABLE 578 FRANCE: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 408 TABLE 579 FRANCE: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 408 TABLE 580 FRANCE: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 409 TABLE 581 FRANCE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 409 TABLE 582 FRANCE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 409 TABLE 583 FRANCE: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 410 TABLE 584 FRANCE: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 410 TABLE 585 FRANCE: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 410 TABLE 586 FRANCE: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 411 TABLE 587 FRANCE: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 411 TABLE 588 FRANCE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 412 TABLE 589 FRANCE: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 412 TABLE 590 FRANCE: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 412 TABLE 591 FRANCE: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 413 TABLE 592 FRANCE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 413 TABLE 593 FRANCE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 414 TABLE 594 ITALY: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 415 TABLE 595 ITALY: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 415 TABLE 596 ITALY: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 415 TABLE 597 ITALY: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 416 TABLE 598 ITALY: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 416 TABLE 599 ITALY: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 416 TABLE 600 ITALY: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 417 TABLE 601 ITALY: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 417 TABLE 602 ITALY: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 417 TABLE 603 ITALY: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 418 TABLE 604 ITALY: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 418 TABLE 605 ITALY: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 419 TABLE 606 ITALY: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 419 TABLE 607 ITALY: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 419 TABLE 608 ITALY: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 420 TABLE 609 ITALY: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 420 TABLE 610 ITALY: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 421 TABLE 611 SPAIN: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 422 TABLE 612 SPAIN: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 422 TABLE 613 SPAIN: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 422 TABLE 614 SPAIN: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 423 TABLE 615 SPAIN: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 423 TABLE 616 SPAIN: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 423 TABLE 617 SPAIN: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 424 TABLE 618 SPAIN: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 424 TABLE 619 SPAIN: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 424 TABLE 620 SPAIN: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 425 TABLE 621 SPAIN: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 425 TABLE 622 SPAIN: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 426 TABLE 623 SPAIN: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 426 TABLE 624 SPAIN: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 426 TABLE 625 SPAIN: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 427 TABLE 626 SPAIN: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 427 TABLE 627 SPAIN: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 428 TABLE 628 NETHERLANDS: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 429 TABLE 629 NETHERLANDS: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 429 TABLE 630 NETHERLANDS: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 429 TABLE 631 NETHERLANDS: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 430 TABLE 632 NETHERLANDS: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 430 TABLE 633 NETHERLANDS: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 430 TABLE 634 NETHERLANDS: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 431 TABLE 635 NETHERLANDS: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 431 TABLE 636 NETHERLANDS: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 431 TABLE 637 NETHERLANDS: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 432 TABLE 638 NETHERLANDS: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 432 TABLE 639 NETHERLANDS: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 433 TABLE 640 NETHERLANDS: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 433 TABLE 641 NETHERLANDS: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 433 TABLE 642 NETHERLANDS: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 434 TABLE 643 NETHERLANDS: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 434 TABLE 644 NETHERLANDS: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 435 TABLE 645 REST OF EUROPE: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 436 TABLE 646 REST OF EUROPE: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 436 TABLE 647 REST OF EUROPE: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 436 TABLE 648 REST OF EUROPE: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 437 TABLE 649 REST OF EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 437 TABLE 650 REST OF EUROPE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 438 TABLE 651 REST OF EUROPE: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 438 TABLE 652 REST OF EUROPE: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 439 TABLE 653 REST OF EUROPE: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 439 TABLE 654 REST OF EUROPE: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 440 TABLE 655 REST OF EUROPE: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 440 TABLE 656 REST OF EUROPE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 441 TABLE 657 REST OF EUROPE: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 441 TABLE 658 REST OF EUROPE: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 441 TABLE 659 REST OF EUROPE: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 442 TABLE 660 REST OF EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 442 TABLE 661 REST OF EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 443 TABLE 662 ASIA PACIFIC: NGS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 444 TABLE 663 ASIA PACIFIC: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 445 TABLE 664 ASIA PACIFIC: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 445 TABLE 665 ASIA PACIFIC: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 445 TABLE 666 ASIA PACIFIC: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 446 TABLE 667 ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 446 TABLE 668 ASIA PACIFIC: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 446 TABLE 669 ASIA PACIFIC: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 447 TABLE 670 ASIA PACIFIC: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 447 TABLE 671 ASIA PACIFIC: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 447 TABLE 672 ASIA PACIFIC: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 448 TABLE 673 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 448 TABLE 674 ASIA PACIFIC: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 449 TABLE 675 ASIA PACIFIC: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 449 TABLE 676 ASIA PACIFIC: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 449 TABLE 677 ASIA PACIFIC: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 450 TABLE 678 ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 450 TABLE 679 ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 451 TABLE 680 CHINA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 452 TABLE 681 CHINA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 452 TABLE 682 CHINA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 452 TABLE 683 CHINA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 453 TABLE 684 CHINA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 453 TABLE 685 CHINA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 453 TABLE 686 CHINA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 454 TABLE 687 CHINA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 454 TABLE 688 CHINA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 454 TABLE 689 CHINA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 455 TABLE 690 CHINA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 455 TABLE 691 CHINA: FOR BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 456 TABLE 692 CHINA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 456 TABLE 693 CHINA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 456 TABLE 694 CHINA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 457 TABLE 695 CHINA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 457 TABLE 696 CHINA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 458 TABLE 697 JAPAN: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 459 TABLE 698 JAPAN: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 459 TABLE 699 JAPAN: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 459 TABLE 700 JAPAN: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 460 TABLE 701 JAPAN: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 460 TABLE 702 JAPAN: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 460 TABLE 703 JAPAN: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 461 TABLE 704 JAPAN: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 461 TABLE 705 JAPAN: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 461 TABLE 706 JAPAN: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 462 TABLE 707 JAPAN: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 462 TABLE 708 JAPAN: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 463 TABLE 709 JAPAN: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 463 TABLE 710 JAPAN: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 463 TABLE 711 JAPAN: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 464 TABLE 712 JAPAN: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 464 TABLE 713 JAPAN: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 465 TABLE 714 INDIA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 466 TABLE 715 INDIA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 466 TABLE 716 INDIA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 466 TABLE 717 INDIA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 467 TABLE 718 INDIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 467 TABLE 719 INDIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 467 TABLE 720 INDIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 468 TABLE 721 INDIA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 468 TABLE 722 INDIA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 468 TABLE 723 INDIA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 469 TABLE 724 INDIA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 469 TABLE 725 INDIA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 470 TABLE 726 INDIA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 470 TABLE 727 INDIA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 470 TABLE 728 INDIA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 471 TABLE 729 INDIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 471 TABLE 730 INDIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 472 TABLE 731 AUSTRALIA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 472 TABLE 732 AUSTRALIA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 473 TABLE 733 AUSTRALIA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 473 TABLE 734 AUSTRALIA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 473 TABLE 735 AUSTRALIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 474 TABLE 736 AUSTRALIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 474 TABLE 737 AUSTRALIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 474 TABLE 738 AUSTRALIA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 475 TABLE 739 AUSTRALIA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 475 TABLE 740 AUSTRALIA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 476 TABLE 741 AUSTRALIA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 476 TABLE 742 AUSTRALIA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 477 TABLE 743 AUSTRALIA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 477 TABLE 744 AUSTRALIA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 477 TABLE 745 AUSTRALIA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 478 TABLE 746 AUSTRALIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 478 TABLE 747 AUSTRALIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 479 TABLE 748 SOUTH KOREA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 480 TABLE 749 SOUTH KOREA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 480 TABLE 750 SOUTH KOREA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 480 TABLE 751 SOUTH KOREA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 481 TABLE 752 SOUTH KOREA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 481 TABLE 753 SOUTH KOREA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 481 TABLE 754 SOUTH KOREA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 482 TABLE 755 SOUTH KOREA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 482 TABLE 756 SOUTH KOREA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 482 TABLE 757 SOUTH KOREA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 483 TABLE 758 SOUTH KOREA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 483 TABLE 759 SOUTH KOREA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 484 TABLE 760 SOUTH KOREA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 484 TABLE 761 SOUTH KOREA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 484 TABLE 762 SOUTH KOREA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 485 TABLE 763 SOUTH KOREA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 485 TABLE 764 SOUTH KOREA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 486 TABLE 765 REST OF ASIA PACIFIC: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 487 TABLE 766 REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 487 TABLE 767 REST OF ASIA PACIFIC: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 487 TABLE 768 REST OF ASIA PACIFIC: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 488 TABLE 769 REST OF ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 488 TABLE 770 REST OF ASIA PACIFIC: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 488 TABLE 771 REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 489 TABLE 772 REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 489 TABLE 773 REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 490 TABLE 774 REST OF ASIA PACIFIC: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 490 TABLE 775 REST OF ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 491 TABLE 776 REST OF ASIA PACIFIC: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 491 TABLE 777 REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 492 TABLE 778 REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 492 TABLE 779 REST OF ASIA PACIFIC: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 493 TABLE 780 REST OF ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 493 TABLE 781 REST OF ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 494 TABLE 782 LATIN AMERICA: NGS MARKET, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 494 TABLE 783 LATIN AMERICA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 495 TABLE 784 LATIN AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 495 TABLE 785 LATIN AMERICA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 495 TABLE 786 LATIN AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 496 TABLE 787 LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 496 TABLE 788 LATIN AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 496 TABLE 789 LATIN AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 497 TABLE 790 LATIN AMERICA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 497 TABLE 791 LATIN AMERICA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 497 TABLE 792 LATIN AMERICA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 498 TABLE 793 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 498 TABLE 794 LATIN AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 499 TABLE 795 LATIN AMERICA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 499 TABLE 796 LATIN AMERICA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 499 TABLE 797 LATIN AMERICA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 500 TABLE 798 LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 500 TABLE 799 LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 501 TABLE 800 BRAZIL: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 501 TABLE 801 BRAZIL: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 802 BRAZIL: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 803 BRAZIL: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 804 BRAZIL: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 503 TABLE 805 BRAZIL: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 503 TABLE 806 BRAZIL: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 503 TABLE 807 BRAZIL: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 504 TABLE 808 BRAZIL: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 504 TABLE 809 BRAZIL: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 504 TABLE 810 BRAZIL: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 505 TABLE 811 BRAZIL: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 505 TABLE 812 BRAZIL: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 506 TABLE 813 BRAZIL: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 506 TABLE 814 BRAZIL: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 506 TABLE 815 BRAZIL: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 507 TABLE 816 BRAZIL: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 507 TABLE 817 MEXICO: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 508 TABLE 818 MEXICO: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 508 TABLE 819 MEXICO: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 509 TABLE 820 MEXICO: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 509 TABLE 821 MEXICO: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 509 TABLE 822 MEXICO: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 510 TABLE 823 MEXICO: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 510 TABLE 824 MEXICO: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 510 TABLE 825 MEXICO: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 511 TABLE 826 MEXICO: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 511 TABLE 827 MEXICO: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 512 TABLE 828 MEXICO: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 512 TABLE 829 MEXICO: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 513 TABLE 830 MEXICO: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 513 TABLE 831 MEXICO: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 513 TABLE 832 MEXICO: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 514 TABLE 833 MEXICO: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 514 TABLE 834 REST OF LATIN AMERICA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 515 TABLE 835 REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 515 TABLE 836 REST OF LATIN AMERICA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 516 TABLE 837 REST OF LATIN AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 516 TABLE 838 REST OF LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 516 TABLE 839 REST OF LATIN AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 517 TABLE 840 REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 517 TABLE 841 REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 518 TABLE 842 REST OF LATIN AMERICA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 518 TABLE 843 REST OF LATIN AMERICA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 519 TABLE 844 REST OF LATIN AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 519 TABLE 845 REST OF LATIN AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 520 TABLE 846 REST OF LATIN AMERICA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 520 TABLE 847 REST OF LATIN AMERICA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 520 TABLE 848 REST OF LATIN AMERICA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 521 TABLE 849 REST OF LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 521 TABLE 850 REST OF LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 522 TABLE 851 MIDDLE EAST: NGS MARKET, BY REGION, 2024–2031 (USD MILLION) 522 TABLE 852 MIDDLE EAST: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 522 TABLE 853 MIDDLE EAST: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 523 TABLE 854 MIDDLE EAST: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 523 TABLE 855 MIDDLE EAST: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 523 TABLE 856 MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 524 TABLE 857 MIDDLE EAST: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 524 TABLE 858 MIDDLE EAST: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 524 TABLE 859 MIDDLE EAST: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 525 TABLE 860 MIDDLE EAST: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 525 TABLE 861 MIDDLE EAST: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 526 TABLE 862 MIDDLE EAST: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 526 TABLE 863 MIDDLE EAST: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 527 TABLE 864 MIDDLE EAST: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 527 TABLE 865 MIDDLE EAST: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 527 TABLE 866 MIDDLE EAST: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 528 TABLE 867 MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 528 TABLE 868 MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 529 TABLE 869 GCC COUNTRIES: NGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 529 TABLE 870 GCC COUNTRIES: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 529 TABLE 871 GCC COUNTRIES: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 530 TABLE 872 GCC COUNTRIES: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 530 TABLE 873 GCC COUNTRIES: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 530 TABLE 874 GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 531 TABLE 875 GCC COUNTRIES: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 531 TABLE 876 GCC COUNTRIES: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 532 TABLE 877 GCC COUNTRIES: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 532 TABLE 878 GCC COUNTRIES: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 532 TABLE 879 GCC COUNTRIES: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 533 TABLE 880 GCC COUNTRIES: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 533 TABLE 881 GCC COUNTRIES: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 534 TABLE 882 GCC COUNTRIES: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 534 TABLE 883 GCC COUNTRIES: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 534 TABLE 884 GCC COUNTRIES: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 535 TABLE 885 GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 535 TABLE 886 GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 536 TABLE 887 SAUDI ARABIA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 537 TABLE 888 SAUDI ARABIA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 537 TABLE 889 SAUDI ARABIA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 537 TABLE 890 SAUDI ARABIA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 538 TABLE 891 SAUDI ARABIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 538 TABLE 892 SAUDI ARABIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 538 TABLE 893 SAUDI ARABIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 539 TABLE 894 SAUDI ARABIA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 539 TABLE 895 SAUDI ARABIA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 539 TABLE 896 SAUDI ARABIA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 540 TABLE 897 SAUDI ARABIA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 540 TABLE 898 SAUDI ARABIA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 541 TABLE 899 SAUDI ARABIA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 541 TABLE 900 SAUDI ARABIA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 541 TABLE 901 SAUDI ARABIA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 542 TABLE 902 SAUDI ARABIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 542 TABLE 903 SAUDI ARABIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 543 TABLE 904 UAE: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 543 TABLE 905 UAE: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 544 TABLE 906 UAE: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 544 TABLE 907 UAE: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 544 TABLE 908 UAE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 545 TABLE 909 UAE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 545 TABLE 910 UAE: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 545 TABLE 911 UAE: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 546 TABLE 912 UAE: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 546 TABLE 913 UAE: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 546 TABLE 914 UAE: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 547 TABLE 915 UAE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 547 TABLE 916 UAE: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 548 TABLE 917 UAE: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 548 TABLE 918 UAE: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 548 TABLE 919 UAE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 549 TABLE 920 UAE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 549 TABLE 921 REST OF GCC COUNTRIES: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 550 TABLE 922 REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 550 TABLE 923 REST OF GCC COUNTRIES: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 551 TABLE 924 REST OF GCC COUNTRIES: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 551 TABLE 925 REST OF GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 551 TABLE 926 REST OF GCC COUNTRIES: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 552 TABLE 927 REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 552 TABLE 928 REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 553 TABLE 929 REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 553 TABLE 930 REST OF GCC COUNTRIES: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 554 TABLE 931 REST OF GCC COUNTRIES: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 554 TABLE 932 REST OF GCC COUNTRIES: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 555 TABLE 933 REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 555 TABLE 934 REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 555 TABLE 935 REST OF GCC COUNTRIES: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 556 TABLE 936 REST OF GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 556 TABLE 937 REST OF GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 557 TABLE 938 REST OF MIDDLE EAST: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 558 TABLE 939 REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 558 TABLE 940 REST OF MIDDLE EAST: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 558 TABLE 941 REST OF MIDDLE EAST: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 559 TABLE 942 REST OF MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 559 TABLE 943 REST OF MIDDLE EAST: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 560 TABLE 944 REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 560 TABLE 945 REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 561 TABLE 946 REST OF MIDDLE EAST: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 561 TABLE 947 REST OF MIDDLE EAST: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 562 TABLE 948 REST OF MIDDLE EAST: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 562 TABLE 949 REST OF MIDDLE EAST: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 563 TABLE 950 REST OF MIDDLE EAST: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 563 TABLE 951 REST OF MIDDLE EAST: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 564 TABLE 952 REST OF MIDDLE EAST: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 564 TABLE 953 REST OF MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 565 TABLE 954 REST OF MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 565 TABLE 955 AFRICA: NGS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 566 TABLE 956 AFRICA: NGS PRODUCTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 566 TABLE 957 AFRICA: NGS CONSUMABLES MARKET, BY TYPE, 2024–2031 (USD MILLION) 567 TABLE 958 AFRICA: NGS PLATFORMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 567 TABLE 959 AFRICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024–2031 (USD MILLION) 567 TABLE 960 AFRICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 568 TABLE 961 AFRICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 568 TABLE 962 AFRICA: NGS PRODUCTS MARKET, BY END USER, 2024–2031 (USD MILLION) 569 TABLE 963 AFRICA: NGS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 569 TABLE 964 AFRICA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 570 TABLE 965 AFRICA: SEQUENCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 570 TABLE 966 AFRICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 571 TABLE 967 AFRICA: NGS SERVICES MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 571 TABLE 968 AFRICA: NGS SERVICES MARKET, BY END USER, 2024–2031 (USD MILLION) 571 TABLE 969 AFRICA: NGS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 572 TABLE 970 AFRICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 572 TABLE 971 AFRICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION) 573 TABLE 972 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, JANUARY 2023–JANUARY 2026 574 TABLE 973 NGS MARKET: DEGREE OF COMPETITION 578 TABLE 974 NGS MARKET: REGION FOOTPRINT 584 TABLE 975 NGS MARKET: OFFERING FOOTPRINT 585 TABLE 976 NGS MARKET: APPLICATION FOOTPRINT 586 TABLE 977 NGS PLATFORMS MARKET: TECHNOLOGY FOOTPRINT 587 TABLE 978 NGS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 590 TABLE 979 NGS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 591 TABLE 980 NGS MARKET: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 593 TABLE 981 NGS MARKET: DEALS, JANUARY 2023–JANUARY 2026 594 TABLE 982 NGS MARKET: EXPANSIONS, JANUARY 2023–JANUARY 2026 595 TABLE 983 ILLUMINA, INC.: COMPANY OVERVIEW 596 TABLE 984 ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED 597 TABLE 985 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 600 TABLE 986 ILLUMINA, INC.: DEALS, JANUARY 2023–JANUARY 2026 601 TABLE 987 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 603 TABLE 988 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 604 TABLE 989 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 607 TABLE 990 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023–JANUARY 2026 608 TABLE 991 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023–JANUARY 2026 609 TABLE 992 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 610 TABLE 993 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED 611 TABLE 994 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 613 TABLE 995 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023–JANUARY 2026 613 TABLE 996 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2023–JANUARY 2026 614 TABLE 997 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 615 TABLE 998 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED 616 TABLE 999 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 618 TABLE 1000 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2023–JANUARY 2026 618 TABLE 1001 F. HOFFMANN-LA ROCHE LTD.: OTHER DEVELOPMENTS, JANUARY 2023–JANUARY 2026 619 TABLE 1002 QIAGEN: COMPANY OVERVIEW 620 TABLE 1003 QIAGEN: PRODUCTS/SERVICES OFFERED 621 TABLE 1004 QIAGEN: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 623 TABLE 1005 QIAGEN: DEALS, JANUARY 2023–JANUARY 2026 624 TABLE 1006 QIAGEN: EXPANSIONS, JANUARY 2023–JANUARY 2026 625 TABLE 1007 DANAHER CORPORATION: COMPANY OVERVIEW 627 TABLE 1008 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED 628 TABLE 1009 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 630 TABLE 1010 DANAHER CORPORATION: DEALS, JANUARY 2023–JANUARY 2026 631 TABLE 1011 DANAHER CORPORATION: EXPANSIONS, JANUARY 2023–JANUARY 2026 631 TABLE 1012 REVVITY: COMPANY OVERVIEW 632 TABLE 1013 REVVITY: PRODUCTS/SERVICES OFFERED 633 TABLE 1014 REVVITY: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 635 TABLE 1015 REVVITY: DEALS, JANUARY 2023–JANUARY 2026 635 TABLE 1016 REVVITY: EXPANSIONS, JANUARY 2023–JANUARY 2026 636 TABLE 1017 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 637 TABLE 1018 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED 638 TABLE 1019 EUROFINS SCIENTIFIC: DEALS, JANUARY 2023–JANUARY 2026 638 TABLE 1020 PACBIO: COMPANY OVERVIEW 639 TABLE 1021 PACBIO: PRODUCTS/SERVICES OFFERED 640 TABLE 1022 PACBIO: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 643 TABLE 1023 PACBIO: DEALS, JANUARY 2023–JANUARY 2026 643 TABLE 1024 PACBIO: EXPANSIONS, JANUARY 2023–JANUARY 2026 644 TABLE 1025 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW 645 TABLE 1026 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS/SERVICES OFFERED 646 TABLE 1027 OXFORD NANOPORE TECHNOLOGIES PLC: DEALS, JANUARY 2023–JANUARY 2026 648 TABLE 1028 OXFORD NANOPORE TECHNOLOGIES PLC: EXPANSIONS, JANUARY 2023-JANUARY 2026 649 TABLE 1029 TAKARA BIO INC.: COMPANY OVERVIEW 650 TABLE 1030 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED 651 TABLE 1031 TAKARA BIO INC.: DEALS, JANUARY 2023–JANUARY 2026 653 TABLE 1032 BGI GROUP: COMPANY OVERVIEW 654 TABLE 1033 BGI GROUP: PRODUCTS/SERVICES OFFERED 654 TABLE 1034 BD: COMPANY OVERVIEW 658 TABLE 1035 BD: PRODUCTS/SERVICES OFFERED 659 TABLE 1036 BD: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 660 TABLE 1037 10X GENOMICS: COMPANY OVERVIEW 661 TABLE 1038 10X GENOMICS: PRODUCTS/SERVICES OFFERED 662 TABLE 1039 PROMEGA CORPORATION: COMPANY OVERVIEW 665 TABLE 1040 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED 665 TABLE 1041 LGC LIMITED: COMPANY OVERVIEW 666 TABLE 1042 LGC LIMITED: PRODUCTS/SERVICES OFFERED 667 TABLE 1043 LGC LIMITED: DEALS, JANUARY 2023–JANUARY 2026 668 TABLE 1044 WUXI BIOLOGICS: COMPANY OVERVIEW 669 TABLE 1045 WUXI BIOLOGICS: PRODUCTS/SERVICES OFFERED 670 TABLE 1046 TECAN TRADING AG: COMPANY OVERVIEW 671 TABLE 1047 TECAN TRADING AG: PRODUCTS/SERVICES OFFERED 672 TABLE 1048 TECAN TRADING AG: DEALS, JANUARY 2023–JANUARY 2026 673 TABLE 1049 TWIST BIOSCIENCE: COMPANY OVERVIEW 674 TABLE 1050 TWIST BIOSCIENCE: PRODUCTS/SERVICES OFFERED 675 TABLE 1051 TWIST BIOSCIENCE: PRODUCT LAUNCHES, JANUARY 2023–JANUARY 2026 676 TABLE 1052 TWIST BIOSCIENCE: DEALS, JANUARY 2023–JANUARY 2026 677 TABLE 1053 AZENTA US INC.: COMPANY OVERVIEW 678 TABLE 1054 AZENTA US INC.: PRODUCTS/SERVICES OFFERED 679 TABLE 1055 AZENTA US INC.: DEALS, JANUARY 2023–JANUARY 2026 680 TABLE 1056 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 702 TABLE 1057 RISK ASSESSMENT 704 FIGURE 1 NEXT-GENERATION SEQUENCING MARKET SEGMENTATION AND REGIONAL SCOPE 59 FIGURE 2 NEXT-GENERATION SEQUENCING MARKET: YEARS CONSIDERED 61 FIGURE 3 MARKET SCENARIO 63 FIGURE 4 GLOBAL NEXT-GENERATION SEQUENCING MARKET, 2024–2031 64 FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NEXT-GENERATION SEQUENCING MARKET 64 FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF NEXT-GENERATION SEQUENCING MARKET 65 FIGURE 7 HIGH-GROWTH SEGMENTS IN NEXT-GENERATION SEQUENCING MARKET 66 FIGURE 8 ASIA PACIFIC TO BE FASTEST-GROWING REGION DURING FORECAST PERIOD 67 FIGURE 9 ADVANCEMENTS IN SEQUENCING PLATFORMS TO DRIVE MARKET GROWTH 68 FIGURE 10 PRODUCTS OFFERING AND US LED NORTH AMERICA’S NEXT-GENERATION SEQUENCING MARKET IN 2025 69 FIGURE 11 CHINA TO EXHIBIT FASTEST GROWTH DURING FORECAST PERIOD 70 FIGURE 12 PRODUCTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 70 FIGURE 13 NEXT-GENERATION SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 71 FIGURE 14 NEXT-GENERATION SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS 79 FIGURE 15 GROWTH OF GLOBAL GDP, 2020–2024 81 FIGURE 16 VALUE CHAIN ANALYSIS 82 FIGURE 17 NEXT-GENERATION SEQUENCING MARKET: ECOSYSTEM ANALYSIS 84 FIGURE 18 AVERAGE SELLING PRICE OF PLATFORMS, BY KEY PLAYER, 2025 (USD) 87 FIGURE 19 AVERAGE SELLING PRICE OF CONSUMABLES, BY KEY PLAYER, 2025 (USD) 88 FIGURE 20 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2025 (USD) 89 FIGURE 21 AVERAGE SELLING PRICE, BY REGION, 2025 (USD) 90 FIGURE 22 NEXT-GENERATION SEQUENCING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 100 FIGURE 23 INVESTMENT & FUNDING SCENARIO, 2023–2025 (USD MILLION) 101 FIGURE 24 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 107 FIGURE 25 KEY BUYING CRITERIA FOR NGS PRODUCTS, BY END USER 108 FIGURE 26 PATENT APPLICATIONS IN NEXT-GENERATION SEQUENCING MARKET, JANUARY 2015–DECEMBER 2025 124 FIGURE 27 IMPACT OF AI/GEN AI ON NEXT-GENERATION SEQUENCING MARKET 127 FIGURE 28 NOVASEQ SERIES (X/X PLUS) PLATFORM SHIPMENTS, 2023–2025 (UNITS) 162 FIGURE 29 MISEQ/MISEQ I100 PLATFORM SHIPMENTS, 2023–2025 (UNITS) 163 FIGURE 30 NEXTSEQ 1K/2K AND 550 PLATFORM SHIPMENTS, 2023–2025 (UNITS) 164 FIGURE 31 NOVASEQ 6000 PLATFORM SHIPMENTS, 2023–2025 (UNITS) 165 FIGURE 32 REVIO PLATFORM REVENUE, 2023–2025 (USD MILLION) 167 FIGURE 33 REVIO PLATFORM SHIPMENTS, 2023–2025 (UNITS) 167 FIGURE 34 SEQUEL II/IIE PLATFORM REVENUE, 2023–2025 (USD MILLION) 168 FIGURE 35 SEQUEL II/IIE PLATFORM SHIPMENTS, 2023–2025 (UNITS) 168 FIGURE 36 VEGA SEQ PLATFORM REVENUE, 2023–2025 (USD MILLION) 169 FIGURE 37 VEGA SEQ PLATFORM SHIPMENTS, 2023–2025 (UNITS) 169 FIGURE 38 NORTH AMERICA: NGS MARKET SNAPSHOT 364 FIGURE 39 ASIA PACIFIC: NGS MARKET SNAPSHOT 444 FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS, 2021–2025 (USD BILLION) 576 FIGURE 41 MARKET SHARE ANALYSIS, 2025 577 FIGURE 42 NGS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 580 FIGURE 43 NGS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 582 FIGURE 44 NGS MARKET: COMPANY FOOTPRINT 583 FIGURE 45 NGS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 589 FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS 592 FIGURE 47 EV/EBITDA OF KEY VENDORS 592 FIGURE 48 ILLUMINA, INC.: COMPANY SNAPSHOT (2025) 597 FIGURE 49 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 604 FIGURE 50 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025) 611 FIGURE 51 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025) 616 FIGURE 52 QIAGEN: COMPANY SNAPSHOT (2025) 621 FIGURE 53 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 628 FIGURE 54 REVVITY: COMPANY SNAPSHOT (2025) 632 FIGURE 55 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024) 637 FIGURE 56 PACBIO: COMPANY SNAPSHOT (2025) 640 FIGURE 57 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY SNAPSHOT (2024) 646 FIGURE 58 TAKARA BIO INC.: COMPANY SNAPSHOT (2024) 651 FIGURE 59 BD: COMPANY SNAPSHOT (2025) 659 FIGURE 60 10X GENOMICS: COMPANY SNAPSHOT (2025) 662 FIGURE 61 LGC LIMITED: COMPANY SNAPSHOT (2024) 667 FIGURE 62 WUXI BIOLOGICS: COMPANY SNAPSHOT (2024) 670 FIGURE 63 TECAN TRADING AG: COMPANY SNAPSHOT (2024) 672 FIGURE 64 TWIST BIOSCIENCE: COMPANY SNAPSHOT (2025) 675 FIGURE 65 AZENTA US INC.: COMPANY SNAPSHOT (2025) 679 FIGURE 66 NEXT-GENERATION SEQUENCING MARKET: RESEARCH DESIGN 691 FIGURE 67 NEXT-GENERATION SEQUENCING MARKET: BREAKDOWN OF PRIMARIES 693 FIGURE 68 NEXT-GENERATION SEQUENCING MARKET: INSIGHTS FROM PRIMARIES 694 FIGURE 69 GLOBAL NEXT-GENERATION SEQUENCING MARKET ESTIMATION, 2025 695 FIGURE 70 NEXT-GENERATION SEQUENCING MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH), 2025 696 FIGURE 71 ILLUSTRATIVE EXAMPLE OF ILLUMINA, INC.: REVENUE ANALYSIS, 2025 696 FIGURE 72 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 697 FIGURE 73 NEXT-GENERATION SEQUENCING MARKET: CAGR PROJECTIONS 700 FIGURE 74 NEXT-GENERATION SEQUENCING MARKET: DATA TRIANGULATION 701

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們